Table 1.
Year | Deltamethrin | Cyfluthrin | Cypermethrin | Control* | ||||
KDT50 mortality | % | KDT50 mortality | % | KDT50 mortality | % | KDT50 mortality | % | |
1998 | 19.2 | 100 | 21.7 | 90.2 | 20.3 | 88.7 | 19 | 100 |
1999 | 23.9 | 100 | 22.6 | 89.14 | 24.2 | 86 | 21.2 | 100 |
2000 | 25.4 | 100 | 28.1 | 82.7 | 27.6 | 78 | 20 | 100 |
2001 | 33.6 | 89.1 | 42.3 | 80.7 | 40.8 | 74.5 | 22 | 100 |
2002 | 38.5 | 90.2 | 51.5 | 77 | 52.8 | 72.5 | 23.2 | 80 |
2003 | 46.2 | 82 | 56.7 | 74 | 61.7 | 67.3 | 22 | 90 |
2004 | 50.8 | 76.1 | 62.9 | 66 | 67.4 | 69.5 | 21.4 | 89 |
2005 | 62.1 | 74 | 72.4 | 64.5 | 74.6 | 66.2 | 22.5 | 85.5 |
2006 | 65.9 | 69.8 | 77.3 | 61 | 83.2 | 60.8 | 25 | 80 |
2007 | 72.7 | 65.2 | 90.2 | 56.6 | 88.4 | 58.4 | 24.5 | 80 |
Mean | 43.83 | 84.64 | 52.57 | 74.18 | 54.10 | 72.19 | 22.08 | 90.45 |
* Deltamethrin